Krystal Biotech, Inc. (KRYS) Operating cash flow 2016–2025
Krystal Biotech, Inc. (KRYS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$200.9MFY2025 · since FY2016: -$1.3M → $200.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $200.9M | +62.7% |
| FY2024 | $123.4M | +239.0% |
| FY2023 | -$88.8M | +11.7% |
| FY2022 | -$100.6M | -109.8% |
| FY2021 | -$47.9M | -83.8% |
| FY2020 | -$26.1M | -39.6% |
| FY2019 | -$18.7M | -97.9% |
| FY2018 | -$9.4M | -142.8% |
| FY2017 | -$3.9M | -196.7% |
| FY2016 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice